Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria-Reference-Cited by-同舟云学术

Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria

Published:2022-03-10 Issue:6 Volume:107 Page:1483-1488
ISSN:1592-8721
Container-title:Haematologica
language:
Short-container-title:haematol

Author:

Nishimura Jun-ichi,Ando Kiyoshi,Masuko Masayoshi,Noji Hideyoshi,Ito Yoshikazu,Mayer Jiri,Griskevicius Laimonas,Bucher Christoph,Müllershausen Florian,Gergely Peter,Rozenberg Izabela,Schubart Anna,Chawla Raghav,Rondeau Jean-Michel,Roguska Michael,Splawski Igor,Keating Mark T.,Johnson Leslie,Danekula Rambabu,Bagger Morten,Watanabe Yoko,Haraldsson Börje,Kanakura Yuzuru

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Reference13 articles.

1. Kanakura Y, Kinoshita T, Nishimura J-I. Paroxysmal Nocturnal Hemoglobinuria - From Bench to Bedside: First edition: Springer Japan. 2017.

2. Devalet B, Mullier F, Chatelain B, Dogné JM, Chatelain C. Pathophysiology, diagnosis, and treatment of paroxysmal nocturnal hemoglobinuria: a review. Eur J Haematol. 2015; 95(3):190-198.

3. Brodsky RA. Paroxysmal nocturnal hemoglobinuria. Blood. 2014; 124(18):2804-2811.

4. Hillmen P, Muus P, Dührsen U. Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria. Blood. 2007; 110(12):4123-4128.

5. Kaplan M. Eculizumab (Alexion). Curr Opin Investig Drugs. 2002; 3(7):1017-1023.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacotherapy for CD55 deficiency with CHAPLE disease: how close are we to a cure?;Expert Opinion on Pharmacotherapy;2024-07-23

2. The Complement System as a Therapeutic Target in Retinal Disease;Medicina;2024-06-05

3. Exploring treatment strategies for paroxysmal nocturnal hemoglobinuria: an overview of registered clinical trials;Current Medical Research and Opinion;2024-05-16

4. Complement inhibition in paroxysmal nocturnal hemoglobinuria: From biology to therapy;International Journal of Laboratory Hematology;2024-04-15

5. Safety Profile of Monoclonal Antibodies and Subsequent Drug Developments in the Treatment of Paroxysmal Nocturnal Hemoglobinuria;Medicina;2024-02-24